Expertise in
13
conditions

Dr. Ali A. Valika

Advanced Heart Failure and Transplant Cardiology | Cardiology
Advocate Health And Hospitals Corporation
133 E Brush Hill Rd, Suite 202, 
Elmhurst, IL 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Referral may be required
Expertise in
13
conditions
Advocate Health And Hospitals Corporation
133 E Brush Hill Rd, Suite 202, 
Elmhurst, IL 

Overview

Ali Valika is an Advanced Heart Failure and Transplant Cardiologist and a Cardiologist practicing medicine in Elmhurst, Illinois.

Dr. Valika is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Heart Failure, Heart Failure with Preserved Ejection Fraction (HFpEF), Pulmonary Edema, and Dilated Cardiomyopathy (DCM).

He is actively involved in clinical research, co-authoring 9 peer reviewed articles and participating in 6 clinical trials. Dr. Valika is currently accepting new patients.

Specialties

Advanced Heart Failure and Transplant Cardiology
Cardiology

Licenses

Internal Medicine in MI

Hospital Affiliations

Elmhurst Memorial Hospital
Advocate Illinois Masonic Medical Center
Advocate Good Samaritan Hospital

Languages Spoken

English
Urdu

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Essence Healthcare
  • INSURANCE PLAN
  • MEDICARE MAPD
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Oscar
  • EPO
  • HMO
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Zing Health
  • MEDICARE MAPD
  • MEDICARE SNP
View 18 Less Insurance Carriers -

Locations

ADVOCATE HEALTH AND HOSPITALS CORPORATION
133 E Brush Hill Rd, Suite 202, Elmhurst, IL 60126
Other Locations
ADVOCATE HEALTH AND HOSPITALS CORPORATION
1508 Aurora Ave, Naperville, IL 60540

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Randomized Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study
Randomized Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study
Enrollment Status: Recruiting
Publish Date: December 11, 2025
Intervention Type: Device, Drug
Study Phase: Not Applicable
A Prospective, Multi-center, Non-randomized, Single Arm Open Label Study of 620 Subjects Receiving the OPTIMIZER Smart With CCM Therapy as Standard of Care
A Prospective, Multi-center, Non-randomized, Single Arm Open Label Study of 620 Subjects Receiving the OPTIMIZER Smart With CCM Therapy as Standard of Care
Enrollment Status: Active_not_recruiting
Publish Date: November 20, 2025
Intervention Type: Device
Hemodynamic-GUIDEd Management of Heart Failure
Hemodynamic-GUIDEd Management of Heart Failure
Enrollment Status: Completed
Publish Date: August 07, 2025
Intervention Type: Device
Study Phase: Not Applicable
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
Enrollment Status: Terminated
Publish Date: November 24, 2023
Intervention Type: Drug
Study Drug: Inhaled treprostinil solution
Study Phase: Phase 3
A Multicenter, Randomized, Open Label, Controlled Study Evaluating the Effectiveness and Safety of Furoscix On-Body Infusor vs Continued Medical Therapy for Worsening Heart Failure
A Multicenter, Randomized, Open Label, Controlled Study Evaluating the Effectiveness and Safety of Furoscix On-Body Infusor vs Continued Medical Therapy for Worsening Heart Failure
Enrollment Status: Completed
Publish Date: August 01, 2023
Intervention Type: Combination product
Study Drug: Furoscix Infusor
Study Phase: Phase 2
Sensible Medical Innovations (Noninvasive) Lung fLuid Status Monitor Allows rEducing Readmission Rate of Heart Failure Patients- a Randomized Controlled Study
Sensible Medical Innovations (Noninvasive) Lung fLuid Status Monitor Allows rEducing Readmission Rate of Heart Failure Patients- a Randomized Controlled Study
Enrollment Status: Terminated
Publish Date: December 29, 2017
Intervention Type: Device
Study Phase: Not Applicable
View 5 Less Clinical Trials

9 Total Publications

Hemodynamic Profiles During Pulmonary Artery Pressure Sensor Implantation: Risk Stratification in Chronic Heart Failure With Reduced Ejection Fraction.
Hemodynamic Profiles During Pulmonary Artery Pressure Sensor Implantation: Risk Stratification in Chronic Heart Failure With Reduced Ejection Fraction.
Journal: Journal of cardiac failure
Published: June 26, 2025
Similar Doctors
Expertise in
10
conditions
Dr. Manreet K. Kanwar
Advanced Heart Failure and Transplant Cardiology | Cardiology
Expertise in
10
conditions
Dr. Manreet K. Kanwar
Advanced Heart Failure and Transplant Cardiology | Cardiology

University Of Chicago

5841 S Maryland Ave, 
Chicago, IL 
 (18.0 miles away)
773-702-1000
Languages Spoken:
English
See accepted insurances

Manreet Kanwar is an Advanced Heart Failure and Transplant Cardiologist and a Cardiologist practicing medicine in Chicago, Illinois. Dr. Kanwar is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Cardiogenic Shock, Heart Failure, Heart Attack, Heart Transplant, and Aortic Valve Replacement.

Expertise in
10
conditions
Dr. Maria R. Costanzo
Advanced Heart Failure and Transplant Cardiology | Cardiology
Expertise in
10
conditions
Dr. Maria R. Costanzo
Advanced Heart Failure and Transplant Cardiology | Cardiology
801 S Washington St Fl 4, 
Naperville, IL 
 (12.7 miles away)
630-600-0700
Languages Spoken:
English, French, Italian, Spanish
See accepted insurances
Accepting New Patients

Maria Costanzo is an Advanced Heart Failure and Transplant Cardiologist and a Cardiologist practicing medicine in Naperville, Illinois. Dr. Costanzo is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Heart Failure, Heart Failure with Preserved Ejection Fraction (HFpEF), Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, and Heart Transplant. Dr. Costanzo is currently accepting new patients.

Expertise in
7
conditions
Dr. Jonathan S. Grinstein
Advanced Heart Failure and Transplant Cardiology | Cardiology
Expertise in
7
conditions
Dr. Jonathan S. Grinstein
Advanced Heart Failure and Transplant Cardiology | Cardiology

The University Of Chicago Medical Center

5841 S Maryland Ave, 
Chicago, IL 
 (18.0 miles away)
773-702-1000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Jonathan Grinstein is an Advanced Heart Failure and Transplant Cardiologist and a Cardiologist practicing medicine in Chicago, Illinois. Dr. Grinstein is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Heart Failure, Cardiogenic Shock, Aortic Regurgitation, Heart Transplant, and Aortic Valve Replacement. Dr. Grinstein is currently accepting new patients.

Frequently Asked Questions about Dr. Ali A. Valika

How do I make an appointment with Dr. Ali A. Valika?

You can book an appointment with Dr. Ali A. Valika by calling their office at 630-782-4050. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Ali A. Valika a top-rated expert for Heart Failure?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Ali A. Valika is classified as an Distinguished expert for Heart Failure, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Ali A. Valika specialize in?

While Dr. Ali A. Valika is a Advanced Heart Failure and Transplant Cardiology, they have specific expertise in Heart Failure, Heart Failure with Preserved Ejection Fraction (HFpEF), and Pulmonary Edema. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Advanced Heart Failure and Transplant Cardiology.

Does Dr. Ali A. Valika participate in research or clinical trials?

Yes. Dr. Ali A. Valika has published 9 articles and abstracts on conditions like Heart Failure. You can view a list of Dr. Ali A. Valika's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Ali A. Valika accept my insurance?

Dr. Ali A. Valika accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 630-782-4050 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Valika's expertise for a condition
ConditionClose
    View All 9 Distinguished Conditions
    View All 33 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile